Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jessica C,Petrov

第一单位： Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.

作者： Jessica C,Petrov ^[1] ; Aakash A,Desai ^[1] ; Gursimran S,Kochhar ^[2] ; Sheena K,Crosby ^[1] ; Jami A,Kinnucan ^[1] ; Michael F,Picco ^[1] ; Jana G,Hashash ^[1] ; Francis A,Farraye ^[1]

作者单位： Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA. ^[1] Division of Gastroenterology, Hepatology and Nutrition, Allegheny Health Network, Pittsburgh, PA, USA. ^[2]

关键词 Crohn’s disease metformin ulcerative colitis

DOI 10.1093/ibd/izae147

PMID 39001616

发布时间 2024-07-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Inflammatory bowel diseases

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study.

Inflammatory bowel diseases

相似文献

Inflammatory bowel diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study.

Inflammatory bowel diseases

相似文献

Inflammatory bowel diseases

相关期刊

检索历史清除